News Focus
News Focus
Post# of 257458
Next 10
Followers 64
Posts 11879
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 224181

Wednesday, 03/20/2019 5:23:36 AM

Wednesday, March 20, 2019 5:23:36 AM

Post# of 257458
Enanta Pharmaceuticals

Enanta Pharmaceuticals (NASDAQ:ENTA) is 3.6% lower after hours on a reported 1.6M-share secondary offering.

Those shares are said to be offered at $97 each, Bloomberg reports. The stock closed today at $103.77, implying a 6.5% discount.

The seller is unknown although one holder has at least 1.6M shares: BlackRock, with 2.57M.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today